Drug details:
Molecular formula: C₂₃H₁₆N₂O₅S

Standard name: 5-[5-[(Z)-(6,7-dimethyl-1-oxo-[1,3]thiazolo[3,2-a]benzimidazol-2-ylidene)methyl]furan-2-yl]-2-hydroxybenzoic acid

Synonym:

5-{5-[(6,7-dimethyl-3-oxo[1,3]thiazolo[3,2-a]benzimidazol-2(3H)-ylidene)methyl]-2-furyl}-2-hydroxybenzoic acid

Curated SMILES: CC1=CC2=C(C=C1C)N3C(=O)/C(=C/C4=CC=C(O4)C5=CC(=C(C=C5)O)C(=O)O)/SC3=N2

Evidence for compound's anti-virulence activity:

Yersinia
Related VF: TTSS secreted effectors
Target: YopH
Drug effect: Targets the phosphotyrosine-binding pocket of YopH.
Max phase: Preclinical (in vitro)
Publication:
Tautz L, et al., 2005. Inhibition of Yersinia tyrosine phosphatase by furanyl salicylate compounds. J Biol Chem 280(10):9400-8.